C-33(S)

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameC-33(S)
Drug Alias NameC-33(S)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 9A inhibitors
TargetsPhosphodiesterase 9A
Therapy Area/IndicationsCardiomyopathy, Hypertrophic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesSun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsCardiomyopathy, Hypertrophic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A